Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ('Tonix” or the 'Company”), a fully-integrated, commercial biotechnology ...
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
U.K. and E.U. regulatory submissions NASHVILLE, Tenn., (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) (“iMDx”) today announced that in February the company completed several ...
23h
Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix" or the "Company"), a fully integrated, commercial biotechnology company, today announced that it has received approval from Nasdaq to ...
In terms of the UPCR reduction, we've recently surveyed investors. They suggest a 47% reduction in UPCR in the interim. What are Vertex's expectations for that and how important is it that you show ...
Three-quarters of kidney transplants in the U.S. come from deceased donors, and donation after circulatory death, in contrast ...
A mother in Laurel, MT is opening up about her battle with a genetic kidney disease and her quest for a donor. Tiffini Gallant has been living ...
In early April 2025, Barrera was back home after dialysis. “It was a Friday afternoon. I had just laid down to take a nap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results